Hong Kong stocks closed (08.11) | Hang Seng Index closed down 1.1%, oil stocks reversed the market and rose, putting pressure on commercial aerospace concepts

The Zhitong Finance App learned that the three major indices of Hong Kong stocks were collectively lower today, and the Hengke Index fell nearly 2%. At the close, the Hang Seng Index fell 1.1% or 284.67 points to 25652.82 points, with a full day turnover of HK$210.942 billion; the Hang Seng State-owned Enterprises Index fell 1.09% to 8528.1 points; and the Hang Seng Technology Index fell 1.93% to 4824.42 points.

CICC believes that since the current rebound in Hong Kong stocks is more of a “relative appeal” underpinned by high technology valuations, high congestion, and high volatility, rather than an “absolute appeal” of a sharp increase in profits, once valuation and sentiment have been restored to average, without the support of improved profits, “odds” will naturally decline.

Blue-chip stock performance

CNOOC (00883) led the blue chip increase. At the close, it rose 3.59% to HK$24.24, with a turnover of HK$1.918 billion. Contributed 20.01 points. Yesterday, the strait negotiations turned from proximity to stalemate. The positions of the two sides hardened simultaneously. International oil prices rebounded sharply by about 5%, and the oil distribution is now once again approaching 90 US dollars.

In terms of other blue-chip stocks, BeiGene (06160) rose 2.63% to HK$218.8, contributing 10.35 points to the Hang Seng Index; Haidilao (06862) rose 2.09% to HK$11.72, contributing 0.7 points to the Hang Seng Index; Old Shop Gold (06181) fell 8.49% to HK$362, dragging down 3.3 points; Zijin Mining (02899) fell 5.8% to HK$35.38, dragging down the Hang Seng Index by 20.02 points.

Popular sector aspects

On the market, all of the large Science Network stocks are turning green. The oil and gas concept rose above the market, and CNOOC rose more than 3%; the innovative drug sector continued to be active, rising by more than 11% after Gacos Yingxi; MLCC set off a wave of price tracking, and the Sanhuan Group rose more than 9%; Yushu Technology's subscription ignited emotions, and some robot concepts rose; on the other side, the launch of the Suzake-3 Yao2 launch vehicle was delayed, and the commercial space sector generally fell; the impasse in US-Iran negotiations pushed up oil prices, and aviation stocks fell under pressure; gold stocks pulled back under pressure, and Lingbao retreated. Gold fell more than 8%.

Oil stocks reversed the market. At the close, CNOOC (00883) rose 3.59% to HK$24.24; CNPC shares (00857) rose 1.78% to HK$9.735; and CNOOC Oilfield Services (02883) rose 1.51% to HK$7.08.

The prospects for US-Iran negotiations were once again overshadowed. Oil prices surged more than 5% on Monday, and Brent crude now approaches 90 US dollars. Trump said that since Iran has proposed war compensation, US negotiators have been instructed to claim compensation from Iran, Iran said it will not negotiate with the US until the end of Trump's term. US strategic oil reserves fell by 6.1 million barrels last week to 298.7 million barrels. Guoxin Securities pointed out that the turbulent geographical situation in the Middle East has led to a significant contraction in the stable supply of crude oil worldwide. The high summer demand season combined with low inventories amplifies price elasticity, and upstream oil and gas companies have sufficient profit elasticity.

The pharmaceutical sector continues to be active. At the close, Gacos-B (01167) rose 11.53% to HK$5.465; Cornerstone Pharmaceutical-B (02616) rose 11.32% to HK$5.95; and Zaiding Pharmaceuticals (09688) rose 5.28% to HK$18.53.

Zhongtai Securities believes that since 2026, China's innovative pharmaceutical industry has gradually entered the value realization stage. The industry logic has moved from relying on BD events to overseas commercialization, clinical data implementation and continuous revenue contribution; the CXO industry has experienced early adjustments, and the demand side has gradually improved; recently, the AI pharmaceutical field has continued to usher in industrial catalysis. With the improvement of AI model capabilities, data accumulation and gradual integration of R&D processes, the application value of AI in drug discovery, clinical development and life science research has continued to increase, and upstream processes such as life science tools, biomodels and experimental platforms have benefited Demand for innovative research and development has resumed.

Gold stocks had the highest decline. At the close, Chifeng Gold (06693) fell 6.01% to HK$36.92; Zijin Mining (02899) fell 5.8% to HK$35.38; and Shandong Gold (01787) fell 4.83% to HK$22.48.

Spot gold dived for a short time in the afternoon, falling from a high of $4,434 per ounce in early trading to below $4,360. On Monday, the US and Burundian markets continued to rise, supported by uncertain prospects for the reopening of the Strait of Hormuz and continuing tension in the Middle East. Market concerns about the upward risk of US inflation have intensified. At the same time, US Cleveland Federal Reserve Chairman Beth Hammark said that the Federal Reserve may need to raise interest rates several times to push the inflation rate down to the central bank's target level of 2%. Currently, the market is focusing on the US CPI data for July, which will be released tomorrow evening.

Commercial space groups are under pressure. At the close, Goldwind Technology (02208) fell 7.99% to HK$10.25; Junda shares (02865) fell 6.05% to HK$17.24; and Asia Pacific Satellite (01045) fell 3.98% to HK$2.17.

According to First Finance, people familiar with the matter confirmed that the launch of the Blue Rocket Space Suzake-3 Yao2 carrier rocket was originally scheduled to be postponed on the morning of August 11. According to an earlier announcement, the temporary control period for the airspace related to the Jiuquan Satellite Launch Center is from 7:40 to 8:27 Beijing time on August 11, 2026. According to CCTV news, at 20:02 on August 10, China used the Long March 7 launch vehicle to launch the China Star 4B satellite at the Wenchang Space Launch Site. The rocket flew abnormally, and the launch mission failed. The specific reason is being further analyzed and investigated.

Popular exotic stocks

Gacos-B (01167) surged after a positive profit. At the close, it was up 11.53% to HK$5.465.

Gacos expects to achieve a net profit of no less than 600 million yuan in the first half of this year, making a profit for the first time. This is mainly due to revenue generated from the global R&D, manufacturing, and commercialization strategic licensing cooperation with AstraZeneca on JAB-23E73 (Pan-KRAS), and revenue from signing licensing and service agreements with Shanghai Allis for KRAS G12C (KRAS G12C) and sitneprotafib.

The Sanhuan Group (06951 ) was strong throughout the day. At the close, it was up 9.62% to HK$117.4.

Demand for AI is strong, and the passive components market is booming. MLCC has set off a wave of price tracking and material grabbing. Some customers ask for goods from major passive component manufacturers such as Guoju and Murata Manufacturing at two to three times in order to obtain sufficient material sources. Guoju admits that demand for MLCCs is indeed very strong. From capacity utilization, new customer projects to long-term demand, we have seen that the market continues to heat up.

Shengbang Co., Ltd. (03661) performed well . At the close, it was up 8.09% to HK$98.2.

According to Xinshixiang, ADI, a major analog chip manufacturer, issued a price increase email and will adjust the price of the entire product portfolio, which will take effect from September 13, 2026. Everbright Securities previously stated that the analog chip industry is entering a price increase cycle. As the domestic analog chip leader, Shengbang Co., Ltd. leads the way as the world's eighth largest revenue in 2025 and the number one in the country, and is expected to benefit from the upward cycle of the industry.

Yingpu Precision (01286) picked up in the afternoon. At the close, it was up 5.29% to HK$9.055.

Impro Precision announced interim results at noon. Revenue of HK$3,018 million increased 23.2% year over year, profit attributable to equity shareholders of HK$421 million increased 21.6% year over year, and proposed an interim dividend of HK8.0 cents per share. The high-horsepower engine terminal market revenue increased significantly by 23.7% year-on-year during the period.

Qiutai Technology (01478 ) is under significant pressure. At the close, it was down 7.21% to HK$6.69.

Qiutai Technology announced that in July 2026, sales of mobile phone camera modules were 35.941 million units, down 9.5% from the previous month and 5% from the previous year; the total sales volume of camera modules and lidar was 38.493 million units, a decrease of 7.2% from the previous year and a decrease of 3.2% from the previous year.